Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161
| Autor: | Bernard W. Futscher, Laurence J. Marton, David E. Stringer, Eugene W. Gerner, George S. Watts, Hagit F. Yerushalmi, Natalia A. Ignatenko |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Proteomics
Cancer Research Chromatin Immunoprecipitation Biology Adenocarcinoma Histones 03 medical and health sciences 0302 clinical medicine Gene expression Biomarkers Tumor Polyamines Tumor Cells Cultured Humans Transcription factor Epigenomics Oligonucleotide Array Sequence Analysis Regulation of gene expression Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Acetylation DNA Methylation HCT116 Cells Molecular biology Neoplasm Proteins Gene expression profiling Histone Oncology Pharmacogenetics 030220 oncology & carcinogenesis DNA methylation Colonic Neoplasms biology.protein CpG Islands DNA microarray |
| Zdroj: | Technology in cancer researchtreatment. 5(6) |
| ISSN: | 1533-0346 |
| Popis: | Polyamine analogs are known to inhibit tumorigenesis at least in part by mimicking some of the regulatory roles of natural polyamines. To begin the identification of those signaling pathways that are involved in differential cellular responses to the synthetic conformationally restricted polyamine analog CGC-11093, we conducted gene expression profiling, proteomic, and genome-wide DNA methylation and histone acetylation analyses of the HCT116 colon adenocarcinoma cell line after treatment with this analog. Gene expression analysis was performed using Affymetrix GeneChip human genome U133 Plus 2.0 arrays. Changes in protein expression were evaluated using 2D polyacrylamide gels followed by LCMS/MS. DNA methylation was measured using 6,800 element CpG island microarrays. Treatment of cells with CGC-11093 at concentrations ranging from 0.1 to 10 μM caused inhibition of cell growth and metabolic activity, but only minimally affected cell viability. Gene expression analysis showed concentration-dependent effects of CGC-11093 on the DNA/RNA binding transcription factor, cell cycle, signaling, transport, cytoskeletal/structural, and serine protease genes. Functional gene analysis revealed distinct expression patterns related to inhibition of cell cycle control, TGF beta signaling, proteasome and RNA polymerase pathways, upregulation of the aminoacyl-tRNA synthesis pathway, and perturbations in the MAPK and Wnt signaling pathways. Microarray results were validated for selected genes with real time RT PCR. Proteomics analysis showed correlative changes in the expression of proteins involved in the regulation of proteasome function (proteasome subunit Y) and tRNA synthesis. CGC-11093 treatment did not produce any detectable changes in DNA methylation or histone acetylation in cells. This study validates specific target pathways for a specific conformationally restricted polyamine analog and suggests the utility of combined gene and DNA methylation microarrays along with proteomic analyses as a useful approach to the evaluation of the mechanisms of action of anticancer drugs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|